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Abstract
Background: Control of the onset of DNA synthesis in mammalian cells requires the coordinated assembly and activation of
the pre-Replication Complex. In order to understand the regulatory events controlling preRC dynamics, we have
investigated how the timing of preRC assembly relates temporally to other biochemical events governing progress into S-
phase.
Methodology/Principal Finding: In murine and Chinese hamster (CHO) cells released from quiescence, the loading of the
replicative MCM helicase onto chromatin occurs in the final 3–4 hrs of G1. Cdc45 and PCNA, both of which are required for
G1-S transit, bind to chromatin at the G1-S transition or even earlier in G1, when MCMs load. An RNA polymerase II inhibitor
(DRB) was added to synchronized murine keratinocytes to show that they are no longer dependent on new mRNA synthesis
3–4 hrs prior to S-phase entry, which is also true for CHO and human cells. Further, CHO cells can progress into S-phase on
time, and complete S-phase, under conditions where new mRNA synthesis is significantly compromised, and such mRNA
suppression causes no adverse effects on preRC dynamics prior to, or during, S-phase progression. Even more intriguing,
hyperphosphorylation of Rb coincides with the start of MCM loading and, paradoxically, with the time in late-G1 when de
novo mRNA synthesis is no longer rate limiting for progression into S-phase.
Conclusions/Significance: MCM, Cdc45, and PCNA loading, and the subsequent transit through G1-S, do not depend on
concurrent new mRNA synthesis. These results indicate that mammalian cells pass through a distinct transition in late-G1 at
which time Rb becomes hyperphosphorylated and MCM loading commences, but that after this transition the control of
MCM, Cdc45, and PCNA loading and the onset of DNA replication are regulated at the post-transcriptional level.
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Introduction
The molecular events involved in regulating the entry of
mammalian cells into the cell cycle and eventually into S-phase are
controlled by soluble growth factors that initiate signals during the
first gap (G1) phase of their division cycle. A key component of
mammalian cells that regulates entry into S-phase, and whose
timely assembly and activation is likely controlled by these growth
factor-induced signals, is the pre-Replication Complex (preRC)
[1]. The preRC marks origins of DNA replication and controls
activation of bidirectional DNA replication from these origins once
S-phase is initiated. The assembly of the preRC involves the
stepwise recruitment of multiple proteins, the nucleation of which
begins with the arrival of the Origin Recognition Complex (ORC)
[2]. This is followed by recruitment of Cdt1 and Cdc6, which
together facilitate the loading of the Mini-Chromosome Mainte-
nance (MCM) complex onto chromatin at the preRC [3,4,5,6,7].
The MCM complex is involved in the unwinding of origin DNA
and is required for elongation of replication forks, strongly
implicating it as the replicative helicase [8,9]. Activation of the
MCM complex requires the recruitment of Cdc45, an apparent
cofactor for MCM function during initiation and elongation steps
[8]. PCNA and DNA polymerases are also recruited prior to
initiating DNA synthesis [10]. In cycling cells, the preRC
assembles during late telophase (mitosis) [11,12], but evidence
suggests that in mammalian cells released from quiescence the
loading of MCMs (final preRC assembly) occurs during late-G1-
phase [13,14,15,16]. This is supported by the results of Mailand
and Diffley [17] where it was shown that Cyclin E/Cdk2 activity,
which is active in middle to late-G1 in cells released from
quiescence (see below), phosphorylates Cdc6 to achieve Cdc6-
dependent MCM loading.
Progress through G1 into S-phase is governed by cyclin proteins
that regulate associated kinases, and the temporal activation of
these kinases properly orchestrates important cell cycle events as
cells progress into S-phase. Included among these kinase
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Cdk2 [18]. Entry into G1 from a quiescent state (G0) is associated
with the expression and activation of Cyclin D/Cdk4, which
causes an initial phosphorylation of the retinoblastoma protein
(Rb) during the first half of G1 [19,20,21,22,23,24]. This
hypophosphorylated form of Rb is now capable of binding to
E2F family members, resulting in suppression of their transcrip-
tional transactivation potential during early G1 [21,25]. In late-G1,
Cyclin E/Cdk2 complexes form and further phosphorylate Rb (in
addition to their role in Cdc6 phosphorylation and MCM
loading), which produces a hyperphosphorylated form of Rb that
is inactivated with respect to its ability to suppress E2F function
[20,24]. Such E2F complexes that are no longer suppressed by Rb
become transactivators at the transcriptional level of genes whose
protein products are required for entry into S-phase [26].
Although there are likely other non-transcriptional functions of
Rb that are altered by its hyperphosphorylation [27], it is generally
thought that the transcriptional activation of new mRNA in late-
G1 for E2F-regulated genes is critical in promoting the final
progression into S-phase. As a corollary, such transcription by
E2F complexes is predicted to be required for preRC assembly in
late-G1.
It has been known for almost three decades that mouse
fibroblasts lose the requirement for ongoing de novo synthesis of
mRNA in late-G1, approximately 3–4 hours prior to S-phase entry
[28,29,30]. At such time, previous studies have shown that
mammalian cells become insensitive to inhibitors of RNA
polymerase II, such as a-amanitin or 5,6-dichloro-ribofuranosyl-
benzimidazole (DRB) [28,29,30]. These results indicate that
mammalian cells have generated the minimum amount of coding
mRNA necessary for G1-S transit prior to 3–4 hours before S-
phase entry, and no longer need any new mRNA production in
late-G1.
Intriguingly, these prior results predict that the loss of need for
de novo mRNA synthesis in late-G1 may overlap the window when
Rb becomes hyperphosphorylated and transcriptional induction of
various E2F-regulated mRNAs would be turned on and
presumably required. As such, this creates a potential conflict for
the Rb-E2F transcriptional induction paradigm, where ongoing
late-G1 de novo transcription is thought to be required for G1-S
transit (and consequently also for preRC assembly). Further, given
that MCM assembly likely occurs in late-G1 after Cyclin E/Cdk2-
dependent Cdc6 phosphorylation [17], another prediction that
can be made from prior studies is that this late-G1 independence
from de novo mRNA synthesis also potentially overlaps the time
when preRCs assemble. This would indicate that ongoing new
mRNA synthesis (including by E2F) is not required for preRC
assembly, consistent with it not being required for G1-S transit.
However, at the moment, any overlaps of such events are only
predictions that can be made from separate reports in the
literature, and have not been directly investigated together
experimentally. Clearly, elucidation of the dynamics and kinetics
of these events during G1-to-S progression will undoubtedly have
important implications for understanding cell cycle control.
To address these predicted potential overlaps in a comprehen-
sive manner with direct experimentation, we have utilized two
model mammalian cell lines to investigate the relationship between
preRC assembly dynamics, Rb hypo- and hyperphosphorylation,
and the window of time during which cells become insensitive to
the suppression of new mRNA synthesis. Using effective synchrony
regimens, we have found that in mammalian cells released from
quiescence the loading of MCM proteins onto pre-established
ORCs begins at 3–4 hours prior to G1-S, consistent with the
timing predicted by the Mailand and Diffley report [17]. When
MCM chromatin loading is first observed, several events do
indeed coincide. Rb becomes noticeably hyperphosphorylated,
and, paradoxically, mammalian cells then lose the requirement for
ongoing de novo synthesis of mRNA (including that of multiple E2F-
regulated targets that were analyzed). We further show that
mammalian cells not only transit into S-phase under conditions of
significantly suppressed mRNA synthesis, but also enter on time
and progress through the majority of S-phase unhindered.
Suppression of mRNA synthesis from late-G1 onward does not
perturb any measured aspects of preRC dynamics, including the
loading and maintenance of MCMs, Cdc45, and PCNA on
chromatin. Consistent with numerous predictions from the
literature, these results provide direct experimental evidence
demonstrating that mammalian cells pass through a unique
transition in the cell cycle that occurs several hours prior to S-
phase and coincides with Rb hyperphosphorylation and the start
of MCM loading. From this transition forward, new mRNA
synthesis is not rate limiting for MCM, Cdc45, or PCNA loading,
nor for the onset of DNA replication.
Methods
Cell Culture and Synchronization
Mouse keratinocytes (Balb/MK) were maintained in low
calcium MEM and supplemented with 8% dialyzed FCS
(Hyclone) and 4 ng/ml EGF (Invitrogen) [30,31]. Chinese
hamster ovary (CHO) cells were maintained in normal MEM
supplemented with 10% Fetal Clone II (Hyclone) [14]. MCF7 cells
were maintained in DMEM (Invitrogen) and 10% FBS (Hyclone).
All cells were cultured in a humidified 5% CO2 environment.
Synchronization of CHO cells in a quiescent state was achieved by
culturing cells for 36 hours in isoleucine-minus MEM supple-
mented with 10% dialyzed FCS [14]. Synchronization of Balb/
MK cells in G0 was achieved by culturing cells in medium lacking
EGF for 3.5 days [30,31]. Cells were re-stimulated to enter the cell
cycle (into G1) by addition of isoleucine-containing MEM or
medium containing EGF.
Nuclear Labeling and Flow Cytometric Analyses
Replicating DNA was labeled by either pulsing for 30 minutes
with bromodeoxyuridine (BrdU; 15 mM) at the indicated time
points, or by continuous labeling with BrdU (20 mM) throughout
the experiment. For time point collection, labeled nuclei were
fixed with 2% formaldehyde at the conclusion of the pulse with
BrdU and stored until all time points were collected. Incorporated
BrdU was detected using immunofluorescent approaches [14,15].
For flow cytometry, cells were trypsinized, collected, and fixed in
cold 70% ethanol at each time point. Fixed cells were stained with
propidium iodide and treated with RNAse A (Sigma) prior to
analysis.
Uridine Incorporation Assays
CHO cells were pulsed with 3 mCi/ml of tritiated-uridine for
1 hr. Pulses were stopped by addition of 1 M citric acid to the
medium. Following three washes with 10% trichloroacetic acid,
labeled cells were lysed with 0.2 N NaOH and equal aliquots were
measured by scintillation counting of duplicate samples.
In Vivo RNA Run-off Assays
A published protocol was used with some modifications [32].
After DRB or DMSO treatment of CHO cells, bromo-uridine
(BrU; Sigma) was added at 100 mM for 2 hr to label newly-
synthesizing RNA. Total RNA was purified as described [33].
RNA was heated to 80 C to denature and subjected to
Rb, preRCs, and mRNA Synthesis
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anti-BrdU antibodies (1 mg/750 ml final; Roche) in the presence of
,10 mg of HeLa total RNA per reaction, and then 1 hr with anti-
mouse secondary agarose beads (Sigma) pre-blocked with HeLa
total RNA and 0.1% BSA. Flow-through was kept, and beads were
washed three times, followed by boiling in DEPC-water. RT-PCR
was performed as described below.
Antibodies Used
The following antibodies were used, with dilutions indicated.
Developed by us using full-length immunogens: rabbit anti-Mcm2
(CHO samples only; 1:5,000; Covance Labs) and chicken anti-
Cdc45 (1:1000; Aves Labs); from Cell Signaling: rabbit anti-Rb-P-
ser807/811 and rabbit anti-Rb-P-ser780 (both 1:500); from
Calbiochem: monoclonal anti-PCNA (1:10,000); from Upstate:
rabbit anti-Cyclin E and rabbit anti-Cyclin A (both 1:1000; CHO
samples only); from Santa Cruz Biotech: monoclonal anti-Lamin
A/C (1:200); from BD Biosciences: monoclonal anti-Orc4
(1:1000), rabbit anti-Mcm2 (MK samples only; 1:3000), and
monoclonal anti-Cyclin E (MK samples only; 1:1000). From
Neomarkers (Thermo-Fisher): monoclonal anti-Cyclin A (MK
samples only; 1:1000); provided by Rolf Knippers (Konstanz,
Germany): rabbit anti-Orc2 (1:1000) and rabbit anti-Mcm5
(1:3000); provided by Steve Hann (Vanderbilt University): rabbit
anti-Myc (1:500).
Reverse Transcriptase PCR
Total RNA was collected by standard techniques [33] and
converted to cDNA. PCR was performed using Taq poly-
merase (Promega) and internal primers against the c-myc,C y c l i n
A2, Cyclin E1, Cdc6, E2F1, DHFR, and PCNA coding
sequences. Primers were designed against Chinese hamster
coding sequences (for DHFR, Cdc6, and PCNA), or against
conserved regions of human and mouse coding sequences (for
Cyclins A2 and E1, c-myc,a n dE 2 F 1 ) .P C Rw a sp e r f o r m e di n
triplicate using multiple amplification cycle numbers (e.g.,2 5 ,
2 7 ,3 0c y c l e s ) ,a n di na l lc a s e ss h o w n ,t h er e s u l t sw e r eo b t a i n e d
from the lowest number of cycles and are below saturation
kinetics. Further PCR conditions and primer sequences are
available upon request.
Immunoblotting Assays
Synchronous cells were washed and scraped into cold PBS. To
determine the total number of cells collected, an aliquot of scraped
cells was removed and resuspended in a HEPES-buffered solution
(pH 7.5) containing 10 mM EDTA to disaggregate cells (15 min
on ice) [14,15]. The approximate cell numbers collected were
determined using a hemacytometer, and samples were then
normalized to cell number (cell numbers never varied by more
than 5%). Equal cell numbers were lysed and boiled directly in
loading dye (for total lysates; TCE samples), or were separated into
detergent-resistant (referred to as P3) or detergent-soluble (referred
to as S1) fractions as described previously [12,14,15]. The
detergent-resistant pellets are operationally defined as chroma-
tin-bound, while the detergent-soluble fraction contains nucleo-
solic and cytosolic proteins. Subunits of the preRC that are present
in the P3/chromatin fraction have been shown to be sensitive to
nuclease digestion and are extractable following such a procedure
[12]. Thus, the S1/P3 pairs of samples had equal volumes of
CHO or Balb/MK cell-equivalent extracts, which were also
equivalent to the TCE lysates. Equal amounts of TCE, S1, and P3
were analyzed by SDS-PAGE and immunoblotting. Standard
immunoblotting techniques were used [34].
Results
Balb/mouse keratinocytes cells lose the requirement for
de novo mRNA synthesis 4 hrs prior to S-phase
It has been known for almost three decades that mouse
fibroblasts (AKR-2B, A31, and BPA-31; latter two related to 3T3
cells) released from quiescence (G0) enter into a unique
biochemical state in late-G1 in which they are no longer
dependent on de novo synthesis of coding mRNA [28,29,30]. This
was shown by determining the times in G1 when cells become
insensitive to two potent and specific inhibitors of RNA
polymerase II function: a-amanitin or 5,6-dichloro-ribofurano-
syl-benzimidazole (DRB) [35,36]. Cells are highly sensitive to
DRB-mediated mRNA suppression in early-G1, but become
DRB-insensitive approximately 3–4 hours prior to the time of S-
phase entry [28,29,30]. Thus, ongoing new mRNA synthesis is
absolutely required in early-G1 and is rate-limiting for cell cycle
progression during this time, but new mRNA synthesis is not rate-
limiting in late-G1 for cell cycle progression (into S-phase).
We have previously reported that Balb/mouse keratinocytes
(Balb/MK, or MK), like murine fibroblasts, also lose the
requirement for de novo mRNA synthesis in late-G1 [30]. We used
synchronized MK cells to re-examine the timing of when this
transition to mRNA transcription independence occurs. MK cells
are EGF dependent in their growth requirements and can be
effectively synchronized and released into G1 using an EGF
deprivation protocol [30]. Such EGF-synchronized MK cells
moving through G1 into S-phase were exposed to DRB at several
time points and allowed to progress (if they could) to the normal
peak of S-phase (15 hrs post-release for MK cells), at which time
they were pulsed with BrdU to determine the percentage of cells
that were capable of entering S-phase in the presence of the DRB
added at earlier times (diagrammed in Figure 1A). Parallel control
cultures were pulsed with BrdU at the same time points to
determine the percentage of MK cells in S-phase at each time
point. In this manner, comparison of the BrdU index for DRB-
treated cells at each time point to the BrdU index for control cells
at each time point allows one to determine when in late-G1,
relative to the G1-S transition, the population loses sensitivity to
DRB. One benefit of designing the experiment this way is that it
takes into account that the population of cells moves through G1
into S-phase in a quasi-synchronous Poisson distribution [30].
As shown in Figure 1B (right side), exposure of MK cells to DRB
at 1 hr (early G1) effectively blocked progression into S-phase,
confirming our previous results [30] that the DRB dose chosen was
biologically potent (also see below) and that MK cells absolutely
require mRNA synthesis in early-G1. Thus, de novo mRNA synthesis
is rate-limitingforcell cycleprogressioninearly-G1.Exposuretothe
carrier, DMSO, from 1 hr onward didnot block progression of MK
cells into S-phase (Fig. 1B, right side). The G1-S transition in EGF-
synchronized MK cells occurs at 12 hrs in the population (defined
when ,50% of control cells are BrdU-positive), and the peak of
DNA synthesis occurs at 15 hrs (Figure 1B, left side). In contrast to
the inhibitory effect of early-G1 treatment with DRB, treatment
with DRB at 9, 10, or 12 hrs had little or no effect on the ability of
MKcellstoenterS-phase,indicating that the cellstransitionedtoan
mRNAsynthesisindependentstate inlate-G1 (Figure 1B,rightside).
Treatment withDRBat8 hrsblocked,50%oftheMKpopulation
from entering S-phase, which indicates that the transition to DRB
insensitivity occurred ,4 hrs prior to the transition of the MK
population into S-phase (i.e.,G 1-S). We conclude that MK cells
require de novo mRNA synthesis in early G1, but transition to an
mRNA synthesis independent state ,4 hrs prior to the G1-S
transition, consistent with our previous findings [30,37].
Rb, preRCs, and mRNA Synthesis
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synthesis 3–4 hours prior to the G1-S transition
Thus far, the lack of need for new mRNA synthesis in late-G1
has only been shown for murine cell types [28,29,30]. We next
determined if the same were true of human cells, but also wanted
to verify that such a phenomenon was not an artifact of
synchronization per se. To address these questions, we utilized an
effective and straightforward extrapolation approach described by
Campisi and Pardee [28] in which asynchronous, logarithmically-
dividing cells are analyzed for DRB sensitivity. In a log population,
Figure 1. De novo mRNA synthesis is not required in the final 3–4 hrs of G1 for entry into S-phase. (A) Diagram illustrating the
experimental design for the data obtained in B.( B) Balb/MK cells were synchronized in G0 by EGF deprivation and then released into the cell cycle by
re-addition of EGF. At the times indicated, control cells were pulsed with BrdU to determine the kinetics of progression through G1 into S-phase (gray
columns on left). Cells treated with 50 mM DRB at the times indicated were allowed to progress to the peak of S-phase at 15 hrs, at which time they
were pulsed with BrdU to determine the percentage of cells that could enter S-phase following different times of DRB exposure (black columns on
right). As a control, the DMSO carrier was added to a parallel culture at 1 hr and remained until the BrdU pulse at 15 hrs (white column on right). The
15 hr untreated control (gray column on right) indicates the maximum number of BrdU-labeled cells obtained. The means of triplicate counts of
,200 cells/field+/21 s. d. are shown. C) Asynchronous, logarithmically growing human MCF7 cells were treated with 50 mM DRB from time zero
(squares), or not treated (circles), during a 24 hr period. BrdU was added at the beginning of the experiment and remained throughout the 24 hr
period. At the indicated times, samples were fixed and processed for BrdU incorporation to determine the percentage of cells that had entered S-
phase. The first time point was exposed to BrdU for 30 min before fixation. The means of triplicate counts of ,250 cells/field+/21 s. d. are shown.
doi:10.1371/journal.pone.0005462.g001
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hours of S-phase and others in early G1. Cells in a log population
that are within a few hours of S-phase when exposed to DRB, but
no longer sensitive to DRB, will continue to progress through late-
G1 into S-phase and incorporate BrdU at similar rates to untreated
control cells [28]. The time after DRB treatment when the rates of
nuclear labeling begin to plateau and diverge from untreated
control populations can be used to extrapolate back to the time in
G1 when the population loses sensitivity to DRB [28].
The results in Figure 1C show that log MCF7 human breast
cancer cells displayed an expected ,28% BrdU labeling index at
the start of the experiment (time 0). At this time, all plates were
treated with BrdU, which was allowed to accumulate into nuclei as
they entered S-phase during the course of the experiment. Half of
the plates were untreated (controls; circles in Figure 1C), to show
the rate of BrdU labeling index increase over time, while the other
half of the plates were exposed to DRB. Figure 1C shows that, as
expected, the percentage of nuclear labeling in control populations
steadily increased during the course of the experiment, achieving
almost 100% labeling by 24 hrs, after all of the cells had a chance
to transit one cell cycle (and thus enter S-phase). In contrast, DRB-
treated populations steadily increased alongside control cells for
only the first 3–4 hours, after which time nuclear labeling
plateaued and diverged from that of control cells (Figure 1C,
squares). These results indicate that MCF7 cells in the log
population that were at cell cycle positions more than 3–4 hrs
prior to S-phase were sensitive to DRB and failed to progress into
S-phase, while those that were within 3–4 hrs of the G1-S
transition at the time of drug treatment were not sensitive to DRB
and entered S-phase unabated. We conclude that human cells, like
murine cells, lose the requirement for ongoing de novo mRNA
synthesis 3–4 hrs prior to S-phase entry, and that this situation is
independent of synchronization. Further, since transformed
murine cells [28], tumor-derived human cells (shown here), and
non-transformed mouse cells [28,29,30] all display this character-
istic, the loss of requirement for de novo mRNA synthesis in late-G1
is independent of the species or transformation status of the cell.
MCM loading occurs in the last 4 hrs of G1-phase in MK
cells
Evidence in the literature has suggested that mammalian MCM
proteins load onto preRCs during the latter part of G1-phase in
cells released from quiescence [13,14,15,16]. We wanted to
determine for MK cells when MCM loading occurred, relative
to the timing of sensitivity to DRB and the underlying need for
mRNA synthesis, since knowledge of this relationship would have
important implications for understanding the mechanisms con-
trolling MCM loading and late-G1 progression into S-phase.
Assembly of preRCs onto chromatin templates (i.e., at future
origins of DNA replication) is operationally defined as the time
when preRC subunits, particularly MCM subunits, display an
increased presence on chromatin pellets based on their resistance
to extraction with non-ionic detergents [11,12,14,15]. To analyze
the chromatin binding characteristics of preRC proteins, EGF-
synchronized MK cells were released into G1 and allowed to
progress into S-phase. At the times indicated, we collected total
protein lysates (TCE), or fractionated separate samples into
detergent-resistant (P3, chromatin) and detergent-sensitive (solu-
ble/S1, cytosolic/nucleosolic) extracts [12,14,15]. Immunoblot-
ting was performed to determine protein binding kinetics within
each fraction/lysate over time. To verify effective fractionation, we
immunoblotted against Lamin A/C, which partitions only with the
chromatin fraction (data not shown, but see ref [14]). Parallel
cultures of MK cells were pulsed with BrdU at the same time
points to determine the kinetics of movement through G1 into S-
phase (Figure 2A). The G1-S transition, as in the above experiment
(Figure 1B), occurred at 12 hrs post-release.
Analysis of the dynamics of Orc4 revealed that it was present
throughout G1- and S-phases at relatively steady levels (Figure 2B,
TCE), and it was completely chromatin-bound at all times
(Figure 2B, chromatin fraction), as seen for ORC in other studies
[11,12,14]. MCM loading, as measured by the analysis of Mcm2
and Mcm5 dynamics, became visible starting at 8 hrs (Figure 2B,
chromatin fraction). While Mcm2 appeared to load onto, and
remain steadily bound to, chromatin from 8 hrs onward, Mcm5
chromatin binding clearly increased from the time period
encompassing 8–12 hrs, after which it remained steady like
Mcm2. Intriguingly, the MCM activators, Cdc45 and PCNA,
both begin binding to chromatin at 8 hrs, with increasing
chromatin association kinetics until 12 hrs (the G1-S transition),
after which both were steadily chromatin bound throughout S-
phase (Figure 2B, chromatin fraction). These results demonstrate
that in MK cells released from quiescence, MCM, Cdc45, and
PCNA loading onto chromatin occurs from 8–12 hrs, directly
overlapping the time in late-G1 when de novo mRNA synthesis is no
longer required for progression into S-phase. This further indicates
that the underlying mechanisms regulating preRC assembly in the
last few hours of late-G1 do not depend on production of new
mRNA and are thus post-transcriptional in nature.
Rb hyperphosphorylation coincides with MCM loading
and the transition to an mRNA synthesis independent
state in MK cells
The hyperphosphorylation of Rb in late-G1 is a well-established
event that is commonly thought to regulate progression into S-
phase by releasing E2F complexes that then cause increased de novo
mRNA transcription of genes required for DNA replication [26].
A corollary of this is that the increased presence of new mRNA
transcripts would likely comprise part of the mechanism governing
preRC assembly. Since we established that MCM, Cdc45, and
PCNA loading occurred in late-G1, and that this directly
overlapped the time in late-G1 when de novo mRNA synthesis is
no longer required by MK cells for entry into S-phase, we wanted
to ascertain the kinetics of Rb hyperphosphorylation relative to
these findings.
As described above, Rb phosphorylation during G1 progression
involves the concerted action of two kinase complexes, Cyclin D/
Cdk4 and Cyclin E/Cdk2 [20,24]. The Cyclin D/Cdk4
complexes phosphorylate Rb as cells enter G1 after growth factor
stimulation, rendering Rb hypophosphorylated and capable of
binding to E2F and blocking E2F-mediated transactivation of
promoters [21]. In late-G1, the Cyclin E/Cdk2 complexes further
phosphorylate Rb, producing the hyperphosphorylated form of
Rb that is associated with transcriptional upregulation events
[21,24,25]. Importantly, the hyperphosphorylation of Rb occurs
on several sites in Rb’s C-terminal region (and in other regions),
and such hyperphosphorylated Rb has been shown to become
easily extractable with non-ionic detergents in late-G1 [24,38,39].
To determine the timing of Rb hyperphosphorylation in MK
cells, we used an antibody specific for Rb phosphorylated on
serines 807 and 811, both of which are in Rb’s C-terminal region
[39]. As can be seen in Figure 2B, Rb-ser807/811P appeared in
MK cells at 8 hrs (Figure 2B, TCE), and as predicted [24], was
completely detergent-extractable (Figure 2B, soluble fraction, note
none in the chromatin fraction). Rb-ser807/811P remained
present through late-G1 into S-phase. These results demonstrate
that hyperphosphorylation of Rb in MK cells appeared around
8 hrs and was maintained thereafter into S-phase. Importantly,
Rb, preRCs, and mRNA Synthesis
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cells coincident with when MCM, Cdc45, and PCNA loading
commences, and Rb is hyperphosphorylated during their entire
loading period in late-G1.
We also analyzed the expression of Cyclins E and A, both of
which may play a role in late-G1 phosphorylation of Rb
[20,24,25,38,40,41]. Whereas Cyclin A appeared from the G1-S
transition onward, Cyclin E was present in early-G1 and slightly
increased at 8 hrs, the time of Rb-ser807/811P appearance
(Fig. 2B). Although it is difficult to confirm the identity of in vivo
kinases for Rb, these results are consistent with published studies
implicating Cyclin E/Cdk2 as the catalytic complex producing
late-G1 phosphorylation of Rb [20,24,25,40,41]. In addition,
besides the Rb effects, the timing of the increased Cyclin E
expression correlates nicely with the beginning of MCM loading,
and Cyclin E is also known to elicit at least part of its cell cycle
control through facilitation of MCM loading via phosphorylation
of Cdc6 [17].
Even more intriguing, the hyperphosphorylation of Rb also
occurs when the MK population transitions to the period in late-
G1 when de novo mRNA synthesis is no longer rate-limiting for
progression into S-phase (i.e.,a t,8 hrs). Significantly, such a
result is in direct opposition to the commonly-accepted paradigm
suggesting that de novo mRNA transcription of a variety of genes is
induced and required for progression into S-phase after Rb is
hyperphosphorylated in late-G1. This indicates that the role of Rb
hyperphosphorylation may extend beyond simple transcriptional
control mechanisms in late-G1. Further, our results make it
interesting to speculate that the control of MCM loading, or at
least its timing, might comprise one potential regulatory target of
Rb hyperphosphorylation in late-G1 (and we discuss other
published studies consistent with this novel idea below). Indeed,
MCM, Cdc45, and PCNA loading, as we have shown above (and
further demonstrate below), is itself a transcriptional-independent
process in late-G1, and the timing of their loading directly
correlates with the appearance and persistence of hyperpho-
sphorylated Rb.
CHO cells lose the requirement for de novo mRNA
synthesis 3 hours prior to S-phase
We wanted to determine if the timing of events described above
for MK cells were also true for other mammalian cell types. To do
this, we utilized Chinese hamster ovary (CHO) cells, which can be
effectively synchronized, but using a very different regimen.
Depriving CHO of isoleucine synchronizes the cells in a quiescent
state, and synchronized CHO that are released into the cell cycle
transit G1-S 9 hrs later, and reach an S-phase peak from 12–
15 hrs [14,15].
In order to determine when CHO cells lose sensitivity to DRB,
synchronized CHO cells were treated with 50 mM DRB at 1, 6
Figure 2. MCM, Cdc45, and PCNA load in the final 4 hrs of G1 in Balb/MK cells. (A) BrdU was pulsed into MK cells at the indicated times
following release from quiescence to determine the kinetics of synchronization and entry into S-phase. (B) In parallel with the BrdU-pulsed samples in
A, MK cells were collected at the indicated times and separated into total cell lysates (TCE), or fractionated into nucleosolic/cytosolic detergent-
soluble extracts (S1) or chromatin-bound detergent-resistant extracts (P3). Immunoblotting with the indicated antibodies was performed on lysates
from equal cell numbers loaded into each lane. The G1-S transition in MK cells (12 hrs after release) is overlayed in gray.
doi:10.1371/journal.pone.0005462.g002
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progress (if they could) to the peak of S-phase (at 12 hrs)
(diagrammed in Figure 3A). At this time, the plates were pulsed
with BrdU to determine the percentage of cells that successfully
progressed into S-phase after DRB treatment. Parallel control
plates (no DRB added) were pulsed with BrdU at the hours
indicated to determine the kinetics of progression through G1 into
S-phase (Figure 3C, left side; examples are shown in Figure 3B).
Consistent with our results for MK cells, CHO cells in early-G1
were highly-sensitive to DRB, but not to the DMSO carrier, and
failed to progress into S-phase when the drug was added 1 hr after
release into G1 (Figure 3C, right side; examples are shown in
Figure 3B). At 8 hrs after release, CHO cells were completely
insensitive to the same dose of DRB and progressed into S-phase
unperturbed with a BrdU-labeling index nearly identical to control
cells (Figure 3B; and 3C, right side). At 6 hrs after release,
treatment with DRB allowed only ,50% of the population to
enter S-phase (Figure 3B; and 3C, right side). Extrapolating back
from the G1-S transition, which occurs at 9 hrs in the population
(Figure 3C, left side), these results indicate that CHO cells lose
sensitivity to DRB ,3 hrs prior to entering S-phase (Figure 3C,
right side). We conclude that CHO cells behave in a similar
manner to that described above for MK cells (as well as for human
[shown here] and other mouse cell types [28,29,30]), and lose the
requirement for de novo mRNA synthesis in late-G1, in this case
,3 hrs prior to entering S-phase.
CHO cells enter S-phase on time, and progress through
S-phase, when de novo mRNA synthesis is suppressed
We wanted to extend our observations thus far, which only
demonstrate that de novo mRNA synthesis is no longer rate-limiting
in late-G1 for progression of mammalian cells into S-phase. We
asked whether suppression of ongoing mRNA production by
DRB, beginning in late-G1, altered the timing of S-phase entry or
the ability of cells to progress through and complete S-phase.
CHO cells were synchronized and released into G1-phase. At
8 hrs (one hr prior to the G1-S transition) half of the cultures were
treated with 50 mM DRB for the remainder of the experiment,
and S-phase entry and progression were measured using BrdU
incorporation and flow cytometry (Figure 3E&F). To verify that
the DRB added at 8 hrs suppresses new mRNA synthesis in an
acute manner (also see below), we analyzed the levels of c-myc
mRNA using RT-PCR, since the c-myc transcript is known to be
labile with a half-life of one hour or less [42,43]. Accordingly,
DRB treatment resulted in a noticeable suppression of c-myc
mRNA within one hour, and a complete absence of the transcript
by 12 hrs, when the cells were in S-phase (Figure 3D).
Analysis of BrdU labeling kinetics showed that control and
DRB-treated populations were indistinguishable, and that both
entered S-phase on time at 9 hrs (Figure 3E). Flow analysis
confirmed this, showing the initial appearance of S-phase cells
precisely at 9 hrs (Figure 3F). Relative to control cells, DRB-
treated populations progress through S-phase unperturbed up to
approximately 15 hrs (Figure 3E&F). We note that there is a
continual presence of a 2N peak in every flow cytometric time
point regardless of condition (Figure 3F). This is often visible for
our CHO cells analyzed by flow cytometry and is likely due to a
portion of the plated culture that does not release from the
synchronization (but is collected for analysis), likely due to overly-
dense regions on the periphery of the plate. In contrast, BrdU-
analyzed fields are consistently gathered from central positions on
the plate, where the cells display similar monolayer densities, and
comparable synchronization and release dynamics.
From 15 hrs onward, the flow dynamics showed that DRB-
treated cells began slowing somewhat relative to control cells,
indicating they exited S-phase with delayed kinetics (Figure 3F).
This is also evident in the BrdU-analyzed population, where more
DRB-treated cells were still in S-phase at 18 hrs, relative to control
cells (Figure 3E). However, as seen in a 27 hr sampling, when
control cells have completed S-phase and have entered a new
cycle, a significant portion of the DRB-treated cells did manage to
finally exit S-phase, but accumulated with a 4N DNA content
indicative of a G2-M arrest (Figure 3F). The latter is likely due to a
need for synthesis of new mRNA species necessary for mitotic
progression, such as that of Cyclin B [44]. We conclude from these
results that, under conditions of mRNA synthesis suppression
beginning in late-G1, CHO cells enter S-phase on time and
progress through a significant portion of S-phase with normal
kinetics (more than half of S-phase), and eventually exit S-phase,
albeit with delayed kinetics.
MCM loading in CHO cells occurs in late-G1 and overlaps
the time when cells no longer require ongoing mRNA
synthesis
We next assessed the dynamics of preRC subunits, particularly
the MCM complex, on chromatin throughout G1 and S-phase in
CHO cells relative to the window of time when de novo mRNA
synthesis was required. Parallel to the BrdU and flow analyses in
Figure 3E&F, we collected total protein lysates (TCE) and
detergent-resistant (P3, chromatin) or detergent-sensitive (solu-
ble/S1, cytosolic/nucleosolic) fractions [12,14,15]. Immunoblot-
ting was performed on these fractions/lysates with the indicated
antibodies (Figure 4).
The Orc2 protein was completely chromatin-bound in a
relatively steady manner throughout the analysis (Figure 4A,
chromatin fraction), similar to that shown above for Orc4 in MK
cells. However, as for MK cells, the MCM complex displayed
different binding kinetics as CHO progressed into late-G1 and S-
phase. Mcm2 and Mcm5 were present at low steady levels in early-
G1 (Figure 4A, G0 through 3 hrs), but were present on chromatin
at noticeably higher levels during S-phase (Figure 4A, 9 hrs
onward). Relative to the lower steady levels on chromatin at 3 hrs
and before, Mcm2 and Mcm5 noticeably increased on chromatin
at 6 hrs, and this increase continued until 9 hrs (i.e., the G1-S
transition) after which time it plateaued (Figure 4A&B). An
enlargement of the MCM immunoblotting results for the
chromatin fraction during the G1 period is shown in Figure 4B
to help illustrate this transition. Cdc45 and PCNA also displayed
differential chromatin binding characteristics as CHO progress
into S-phase, but unlike that for MK cells, both proteins became
chromatin-bound at the G1-S transition rather than in late-G1
(Figure 4A, chromatin fraction).
Suppression of de novo mRNA synthesis with DRB treatment one
hour prior to the G1-S transition did not change the expression
levels, nor chromatin-binding dynamics, of Orc2, Mcm2, Mcm5,
Cdc45, or PCNA (Figure 4A). This is consistent with the fact that
the CHO cells treated with DRB enter and progress through S-
phase (Figure 3E&F). The expression of labile c-Myc protein, as a
consequence of reduction of its coding mRNA (Figure 3D), was
significantly reduced by the DRB treatment during the S-phase
time points (Figure 4A, TCE, 12–18 hrs). The latter indicates that
the DRB is highly effective and enduring in the experiment. We
conclude from these results that MCM, Cdc45, and PCNA
maintenance on chromatin during S-phase is not dependent on the
ability of CHO cells to continually transcribe new mRNA.
Further, since we established above that, beginning ,6 hrs
following release into G1, CHO cells no longer require de novo
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PLoS ONE | www.plosone.org 7 May 2009 | Volume 4 | Issue 5 | e5462Figure 3. CHO cells do not require de novo mRNA synthesis during late G1, or for progression through S-phase. (A) Diagram illustrating
the experimental design for the data obtained in B&C.( B&C) CHO cells were synchronized in G0 by isoleucine deprivation and then released into the
cell cycle by re-addition of complete medium. At the times indicated, control cells were pulsed with BrdU to determine the kinetics of progression
through G1 into S-phase (gray columns on left in C; examples shown in B). Cells treated with 50 mM DRB at the times indicated were allowed to
progress to the peak of S-phase at 12 hrs, at which time they were pulsed with BrdU to determine the percentage of cells that could enter S-phase
following different times of DRB exposure (black columns on right in C; examples shown in B). As a control, the DMSO carrier was added to a parallel
culture at 1 hr and remained until the BrdU pulse at 12 hrs (white column on right in C). The 12 hr untreated control (gray column on right in C)
indicates the maximum number of BrdU-labeled cells obtained without drug treatment. The means of triplicate counts of ,200 cells/field+/21s .d .
are shown. (D) RT-PCR analysis of c-myc mRNA levels on samples collected at the indicated times, with and without DRB exposure at 8 hrs. (E)
Synchronized CHO cells were untreated (control, top row), or treated with 50 mM DRB at 8 hrs (bottom row), and pulsed with BrdU at each time point
indicated in order to measure progression into and through S-phase. At least three fields of ,200 cells were scored, and averages are displayed in
panels with representative fields. Standard deviations (not shown) were within 1–5% for all panels. (F) Parallel to the samples in E, cells were collected
and processed by flow cytometry using PI staining.
doi:10.1371/journal.pone.0005462.g003
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MCM, Cdc45, and PCNA loading onto chromatin during the final
6–9 hrs of G1 is also not dependent on de novo mRNA synthesis.
Thus, MCM, Cdc45, and PCNA loading in late-G1 or at the G1-S
transition is regulated at the post-transcriptional level in CHO
cells, consistent with our findings in MK cells.
Rb hyperphosphorylation coincides with MCM loading
and the transition to an mRNA synthesis independent
state in CHO cells
We wanted to determine the kinetics of Rb hyperphosphoryla-
tion in CHO cells as it related to the dynamics of MCM loading
and the transition to an mRNA synthesis independent state in
CHO cells. To do this, we analyzed the kinetics of appearance of
two phosphorylated forms of Rb: Rb-ser807/811P and Rb-
ser780P, using phospho-specific antibodies that could both
recognize the CHO species of Rb.
As cells enter the cell cycle, the Cyclin D/Cdk4 complex is
activated by growth factors and phosphorylates Rb in early-G1,
producing an active hypophosphorylated form of Rb [21,24]. One
site on Rb that has been shown to be a substrate for Cyclin D/
Cdk4 is serine 780 [41]. Consistent with these findings, Rb was
indeed phosphorylated on serine 780 in early-G1 in CHO cells,
and there were two prominent phosphorylated forms of Rb that
contained this ser780P residue (Fig. 4A, TCE, G0-6 hrs, lower two
arrows). At 6 hrs, a slower form of Rb-ser780P became more
prominent, and this slower form was present throughout late-G1
and into S-phase (Fig. 4A, TCE, 9–12 hrs, uppermost arrow), in
agreement with studies shown previously in CHO cells [45]. The
slower form of Rb-ser780P is consistent with it being a
hyperphosphorylated form of Rb due to its late-G1 appearance
and slower mobility. Furthermore, hyperphosphorylated Rb is
detergent-extractable [24], and the slower Rb-ser780P form of Rb
is completely detergent-extractable (Fig. 4A, compare soluble
fraction vs. chromatin fraction).
As a further confirmation that hyperphosphorylated Rb was
present at 6 hrs, the C-terminally phosphorylated form of Rb, Rb-
ser807/811P, was analyzed. Rb-ser807/811P clearly appeared at
6 hrs in CHO cells and remained present throughout late-G1, the
G1-S transition, and S-phase (Figure 4A). As expected for
hyperphosphorylated Rb, Rb-ser807/811P was completely deter-
gent-extractable (Figure 4A, soluble fraction). We also analyzed
the expression of Cyclins E and A, both of which may play a role
in Rb phosphorylation in late-G1. Cyclin A appeared at the G1-S
transition, several hours after the appearance of hyperpho-
sphorylated Rb (Figure 4A). However, Cyclin E was present in
early-G1 and slightly increased in expression at 6 hrs, the time
when hyperphosphorylated Rb became prominent (Figure 4A).
These results are consistent with evidence suggesting that Cyclin
E/Cdk2 is involved in the late-G1 appearance of hyperpho-
sphorylated Rb [20,24]. We conclude from these results that Rb is
hyperphosphorylated in CHO cells at ,6 hrs after release into G1,
coinciding with two important events: the increased loading of the
Figure 4. MCM, Cdc45, and PCNA load in the final 3 hrs of G1 in CHO cells. (A) Parallel to the BrdU and flow cytometry collection in Figure 3
E&F, CHO cells (half treated with DRB at 8 hrs) were collected and separated into total cell lysates (TCE), or fractionated into nucleosolic/cytosolic
detergent-soluble extracts (S1) or chromatin-bound detergent-resistant extracts (P3). Immunoblotting with the indicated antibodies was performed
on lysates from equal cell numbers loaded into each lane. The G1-S transition in CHO cells (9 hrs after release) is overlayed in gray. (B) An enlargement
of the time points from part A for hours G0 through 9 is shown for Mcm2 and Mcm5 immunoblots.
doi:10.1371/journal.pone.0005462.g004
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synthesis independent state in the cells. These findings in CHO
cells are very consistent with that determined above for MK cells,
where evidence of Rb hyperphosphorylation, MCM loading, and
the transition to mRNA independence also overlap in the final
third of G1.
Interestingly, except for perhaps a small increase in the presence
of Rb-ser780P from 9 hrs onward (Figure 4A, only visible in
soluble fraction), treatment with DRB one hour prior to S-phase
had no effect on the dynamics of any of these phosphorylated
forms of Rb, nor on Cyclin E expression (Figure 4A). However,
although the appearance of Cyclin A at G1-S was not affected by
DRB treatment, Cyclin A expression was reduced somewhat at
later time points in S-phase by DRB (Figure 4A), perhaps
contributing to the delay of exit from S-phase following DRB
treatment of CHO cells (Figure 3E&F). Nonetheless, since CHO
cells lose the requirement for de novo mRNA synthesis several hours
prior to S-phase, we conclude from these results that the
appearance, maintenance, and dynamics of hyperphosphorylated
Rb and Cyclin E, as well as the initial appearance of Cyclin A, are
regulated primarily at the post-transcriptional level in late-G1 and
thereafter.
Entry of CHO cells into S-phase is not dependent on
induction of E2F-regulated mRNAs in late-G1
The coincident late-G1 timing of Rb hyperphosphorylation,
MCM loading, and the transition to an mRNA synthesis
independent state suggested, paradoxically, that for mammalian
cells to assemble preRCs and successfully proceed into S-phase
from this transition point, induction of new mRNA synthesis by
E2F following ‘release’ from the Rb protein was unlikely to be
required. To address this important question, we first verified that
our DRB treatment was suppressing significant levels of mRNA
synthesis as shown by prior reports, and then determined if several
archetypal E2F-regulated mRNA targets are indeed suppressed by
DRB in our experiments.
DRB is a potent and selective inhibitor of RNA polymerase II
and has been shown at doses similar to ours to acutely inhibit
production of 95% of cellular mRNA (polyadenylated RNA) by 3–
5 minutes of exposure to mammalian cells [35]. Used in this
manner, DRB has little effect on rRNA and tRNA production
[35], both of which must be synthesized by RNA polymerases I
and III, respectively, for cell viability [28,30,35]. Using [3H]uri-
dine incorporation assays (into newly-synthesized RNA of all
types), Darnell and colleagues showed clearly that treatment with
DRB alone produces an ,60% reduction in total uridine
incorporation that is attributable to suppression of specifically
mRNA synthesis. The remainder of uridine incorporation is
attributable to rRNA and tRNA production, but mostly that of
rRNA [35]. Using the same approach, we show in Figure 5A that
exposure of CHO cells to 50 mM DRB results in a very similar
reduction of total uridine incorporation (just over 50%) that is
maximal at (or prior to) 30 minutes post treatment, the latter
consistent with the acute nature of DRB-mediated suppression of
RNA pol II activity.
Low doses of Actinomycin D (0.05 mg/ml) specifically block
rRNA production without affecting mRNA production
[35,36,46,47]. To demonstrate that the remainder of uridine
incorporation not suppressed by DRB is primarily attributable to
rRNA synthesis, we performed another experiment based on that
done by Darnell and colleagues [35]. CHO cells were treated with
DRB (50 mM), ActD (0.05 mg/ml), or DRB+ActD for 30 minutes,
Figure 5. DRB effectively suppresses mRNA synthesis and acutely blocks the expression of E2F-reglated targets. (A) Asynchronous
CHO cells were treated with 50 mM DRB or DMSO carrier at time 0, and [3H]-uridine (3 mCi/ml) was added to the cultures for 1 hr starting at 30 min or
2 hrs post treatment. For time 0 uridine pulse, no DRB or DMSO was added. TCA-precipitable counts were determined by a scintillation machine for
duplicate samples, and the averages were plotted+/21 s.d. as percentages of the DMSO control. (B) CHO cells were treated with DRB (50 mM), DMSO,
ActD (0.05 mg/ml), or DRB+ActD for 30 min, and were then labeled with [3H]-uridine for 1 hr. TCA-precipitable counts were determined as above. (C)
In vivo RNA run-off assay. DRB was exposed to CHO cells for 10 min, then total RNA was labeled for 1 hr with BrU (100 mM). BrU-labeled RNA was
purified as described in the Methods, and then analyzed by RT-PCR using primers against the E2F targets indicated. Input and flow-through samples
were analyzed by RT-PCR for PCNA presence to verify loading and confirm that RNA was not degraded before, during, or after the IP step. (D) RNA
samples from the experiment in Fig. 3D were subjected to RT-PCR analysis using primers against the E2F targets indicated. 5S RNA is shown as a
loading control, as it is much less susceptible to DRB suppression than mRNA.
doi:10.1371/journal.pone.0005462.g005
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produced an ,63% reduction of uridine incorporation, while
ActD alone suppressed ,35% of the incorporation. DRB and
ActD together produced an ,90% reduction, demonstrating as
before [35] that the two pools of uridine suppression are distinct
and the effects of the drugs are additive. We conclude from these
results that DRB indeed suppresses a significant amount of mRNA
synthesis in CHO cells, with the remainder of RNA production
not blocked by DRB due primarily to rRNA synthesis.
We next verified that several well-documented E2F target
genes/mRNAs are indeed acutely suppressed by DRB in our
CHO experiments. In the first approach, we treated CHO cells
with DRB or DMSO for 10 min, then pulsed cells with bromo-
uridine (BrU) to label newly-synthesized RNA (an in vivo RNA run-
off assay). Total RNA was collected and nascent RNA was further
purified using anti-BrdU antibodies (which cross-react with BrU),
converted to cDNA, then subjected to PCR amplification using
primers to several E2F targets. Figure 5C shows that after just
10 min of DRB exposure, the production of new Cyclin A2, Cdc6,
E2F1, DHFR, and PCNA mRNAs is efficiently blocked by DRB
(we also tried to test for Cyclin E1 expression in this assay, but
could not detect any signals after purification; however, Cyclin E1
was examined in the next experiment). We analyzed input and
flow-through samples for PCNA signal to verify that RNA
degradation had not occurred during any part of the purification
procedure (Fig. 5C, bottom). This indicates that, consistent with
the Darnell report [35], RNA polymerase II activity and the
promoters for these well-established E2F targets, in particular, are
significantly suppressed almost immediately after DRB exposure in
our experiments.
Finally, we verified that DRB does indeed acutely block the
induction of new mRNA synthesis of these same E2F targets in our
CHO synchronization experiment (Fig. 3), while at the same time
having no negative effect on the ability of the cells to enter S-
phase. We already showed that c-myc mRNA expression (c-myc is
also E2F-regulated) is acutely blocked after treatment with DRB
prior to S-phase entry (Fig. 3D). Using the same RNA samples for
PCR, we find that the induction of Cyclin A2, Cyclin E1, Cdc6,
DHFR, PCNA, and E2F1 coding mRNAs is also acutely blocked
by DRB added in late-G1 (Fig. 5D), but the cells nonetheless
successfully approach and pass through the G1-S transition (Fig. 3).
In fact, the levels of each of their mRNAs may even be lower after
DRB exposure (likely due to normal degradation of remaining
molecules). Note that in control samples across 8–9 hrs these
mRNAs are clearly seen to increase, as predicted, as cells approach
and enter S-phase. We conclude from these results that CHO cells
do not require de novo synthesis of mRNA in the last few hours of
G1, after Rb hyperphosphorylation, and that, in particular, the
subsequent induction of E2F-regulated genes at the mRNA level is
not strictly required for progress into S-phase. One possible
concern with this interpretation is that untested or unidentified
E2F-regulated genes may exist that are insensitive to DRB but
must be induced for S-phase entry. This possibility is very unlikely,
however, as it has been shown that E2F transactivation in general
is not required for cell cycle progression [48], a finding that is
completely consistent with those presented here, and which is
discussed in more detail below.
Discussion
We have carefully defined the kinetics of several important cell
cycle regulated, as well as cell cycle regulating, events that occur as
mammalian cells progress through G1 into S-phase. Several
conclusions can be drawn from these experiments, with significant
implications for understanding how progression into S-phase is
controlled in late-G1. Studies dating back almost three decades
have suggested that new mRNA synthesis is not required by
mammalian cells in the late-G1 period, while separate work from
other studies has established a general paradigm in which Rb
becomes phosphorylated in late-G1, freeing E2F to induce new
transcription of mRNA for genes required for S-phase entry.
Clearly, these concepts appear to be in opposition to one another,
and one explanation for such conflicting information may derive
from the fact that these concepts have been developed in separate
studies using different cell lines and non-overlapping analyses.
Importantly, some of the novelty of the experimental results we
have shown here derives from the fact that, in contrast to prior
studies, we obtained our results from comprehensive experiments
in which multiple concepts were co-analyzed to determine if
predictions from the literature were valid.
In MK cells, which have a 12 hr G1-phase, MCM loading
occurs from 8–12 hrs post-release. In CHO cells, which have a
9h rG 1-phase, MCM loading occurs from 6–9 hrs post-release.
Thus, in both cell types, MCM loading occurs in the final 33% of
G1-phase (Figure 6), which is consistent with the predictions that
can be made from the results of Mailand and Diffley indicating
that Cyclin E/Cdk2 activity in late-G1 is required for phosphor-
ylation/stabilization of Cdc6 to achieve MCM loading during
such time [17]. While the concept that MCM loading occurs in
this latter part of G1 can be predicted from the Diffley study [17]
and from other studies [13,14,15,16], when one considers the
relationship of this information to the timing of Rb hyperpho-
sphorylation and the transition to mRNA synthesis independence
(both sets of information obtained in parallel, and discussed
below), several significant conclusions can be drawn that have
important implications for understanding how mammalian cells
control late-G1 progression into S-phase.
We demonstrate that, as predicted from several independent
studies, at the time MCM complexes load onto chromatin in late-
G1, at least two important transitions do indeed occur that have
regulatory implications for MCM loading. In both MK and CHO
cells, MCM loading coincides with the appearance of hyperpho-
sphorylated Rb and with the transition to an mRNA synthesis
independent state in the cells (Figure 6). This indicates that the
ongoing synthesis of new mRNA transcripts in late-G1 is not
required to regulate MCM loading onto chromatin via control of
other factors required for this process. Indeed, in both cell types
analyzed here, MCM subunits are present even in early-G1 prior
to this transition, and in CHO cells in particular, the total protein
levels of MCM subunits do not fluctuate at all during G1 or S-
phase in the presence of DRB (Figure 4, TCE samples). A similar
situation exists for Cdc45 and PCNA, where their expression and
loading are also independent of de novo mRNA synthesis in late-G1.
One possible outcome of these experiments might have been that
preRC assembly or dynamics was affected by the block to new
mRNA synthesis, but that any reduction in preRC assembly/
dynamics had no effect on entry into S-phase. Clearly, our results
show that this is not the case, and that blocking new mRNA
synthesis in late-G1, concurrent with the timing of preRC
assembly, has no observable effects on any measured aspect of
preRC dynamics. As a corollary, these data suggest that any
mRNA transcripts required for MCM, Cdc45, or PCNA protein
translation, or for other factors involved in the loading of these
proteins onto chromatin, would likely have been made at sufficient
levels prior to time when cells lose their requirement for new
mRNA production and begin MCM loading.
Given the concepts just described, it is particularly intriguing
that the appearance of hyperphosphorylated Rb coincides not only
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to a cell cycle state that no longer depends on de novo mRNA
synthesis for progression into S-phase. Independent reports in the
literature predicted that these overlaps might exist, and we have
now shown direct experimental evidence that these overlaps do
indeed exist. It is a generally assumed paradigm that transcrip-
tional activation mechanisms involving new mRNA synthesis
control traverse through late-G1 following hyperphosphorylation
of Rb and release of E2F complexes [26]. Indeed, there is a wealth
of evidence in the literature demonstrating that transcription of
numerous genes, whose protein products are important for G1-S
transit, is controlled by Rb-E2F in a positive manner
[25,49,50,51,52,53,54,55,56].
As a corollary to this paradigm, though, such E2F-regulated
transcription (and mRNA synthesis in general) should be rate-
limiting in late-G1 for progress into S-phase. To date, however, no
studies have demonstrated that E2F-regulated transactivation in
late-G1, while definitely occurring, is truly required to occur. Here,
we have addressed this question for the first time. In direct
opposition to this paradigm, we show that new mRNA synthesis is
not rate-limiting for entry into S-phase, at a time that coincides
with, and continually overlaps thereafter, the appearance of Rb
hyperphosphorylation. Furthermore, we show direct evidence that
multiple well-documented E2F targets can be acutely blocked by
DRB from being transactivated in late-G1, but mammalian cells
nonetheless continue into S-phase unhindered. Thus, although up-
regulation of new mRNA after hyperphosphorylation of Rb and
E2F ‘freeing’ in late-G1 clearly does occur, the cells are not
dependent on de novo late-G1 production of these new mRNA
transcripts for successful progression into S-phase. Furthermore,
our data even demonstrates that mammalian cells can progress
through much of S-phase unperturbed when de novo mRNA
synthesis is continually suppressed from late-G1 onward.
Consistent with the work presented here, Dean and colleagues
provided paradoxical evidence that E2F1-mediated transcriptional
activation per se is not required for cell cycle progression [48].
Ectopic expression of an E2F1 protein that is lacking its
transactivation domain, and predicted to act as a dominant-
negative protein because it cannot induce transcription of
important genes required for cell cycle progression, instead allows
normal cell growth [48]. Rather than transcriptional activation
being an important regulatory mechanism of E2F1, it was instead
shown that transcriptional downregulation by E2F1, via Rb
recruitment, was the important function of E2F1 (when cells were
subjected to negative growth signals) [48]. Thus, although E2F1 is
capable of upregulating transcription, transcriptional activation per
se by E2F1 is paradoxically not required by cells at any time in the
cell cycle [48]. Such results also argue strongly that even if we have
missed certain E2F-regulated targets in our analysis (it is not
practical to examine all E2F targets, as some may not yet have
been identified), it is highly unlikely that transcriptional upregulation
of any E2F-regulated genes in late-G1 is required for entry into S-
phase.
Other intriguing evidence exists demonstrating that Rb
suppression of entry into S-phase is separable from negative
effects on transcriptional control by E2F1 [57]. In Saos-2 cells that
are lacking Rb, expression of Rb causes a G1 arrest and an
expected decrease in the mRNA levels of E2F1-regulated genes
such as cyclin A, E, and E2F1, consistent with the Rb-E2F1 model
of transcriptional downregulation [26,57]. However, the expres-
sion of the protein products encoded by these genes is not acutely
suppressed even though the cells fail to enter S-phase [57]. Thus,
although E2F1-sensitive transcription is indeed suppressed by Rb
expression, these results strongly argue that E2F1-mediated
transcriptional control over the presence of these proteins does
not acutely regulate G1-S progression. Importantly, both of the
studies discussed above [48,57] are in complete agreement with
our data presented herein indicating that in late-G1, transactiva-
tion of new mRNA species by E2F1, or by other transcription
factors, is not required for successful G1-S progression, including
the final assembly and activation of preRCs.
Given the problems described above with the conventional
paradigm that Rb-E2F transcriptional events control G1-S transit
in late-G1, it appears that the role of Rb-E2F in late-G1 needs to
be revisited. Intriguingly, the coincidence of Rb hyperphosphor-
ylation and MCM chromatin loading makes it interesting to
speculate that a regulatory relationship may exist between these
two events. Hyperphosphorylation of Rb may constitute a trigger
in late-G1 that facilitates MCM loading, in a manner that does not
depend on new mRNA production to achieve MCM loading and
G1-S transit. Indeed, blocking Rb hyperphosphorylation by
overexpressing the Cdk4 inhibitor p16 results in a block toward
MCM loading that is dependent on the presence of Rb [58]. Thus,
MCMs cannot load when Rb is hypophosphorylated, but we show
here that MCMs do load coincident with, and overlapping, Rb
hyperphosphorylation. Furthermore, the Orr-Weaver lab has
Figure 6. Summary of results described in this report. Mammalian cells require ongoing mRNA synthesis in the first part of G1-phase.
Concurrent with this timeframe, the Rb protein is hypophosphorylated and MCMs have not loaded onto chromatin at the preRCs. In the final 3–
4 hours of G1-phase, mammalian cells pass through a transition when Rb is hyperphosphorylated, MCMs load onto chromatin, and new mRNA
synthesis is no longer rate-limiting for MCM, Cdc45, or PCNA loading, nor for the eventual progression of the cells into and through S-phase.
doi:10.1371/journal.pone.0005462.g006
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origin activity through interaction with the preRC/ORC [59,60].
Significantly, this control over preRC/origin activity in these
studies was via a direct interaction between Rb-E2F and the
preRC components, and did not involve any de novo mRNA
regulation by Rb-E2F [59], which is completely compatible with
the results shown here. While validation of this potential
regulatory relationship in mammalian cells will require further
mechanistic investigation well beyond the scope of this study, the
results presented here clearly demonstrate that mammalian cells
transition into a unique preRC assembly state in late-G1 that is
controlled by post-transcriptional mechanisms following Rb
hyperphosphorylation.
Finally, aside from the concepts discussed above, there is
another result from these studies that merits some analysis. In
CHO cells, Cdc45 and PCNA loading occurs prominently at the
G1-S transition. However, in MK cells, Cdc45 and PCNA loading
overlap MCM loading during the final 4 hrs of G1, and thus
occurs noticeably earlier than the G1-S transition. Cdc45
recruitment has been shown to be dependent on the activity of
Cdk2 and Cdc7 kinases in metazoans [61], and in yeast,
recruitment of Cdc45 along with specific phosphorylation events
triggers G1-S transit at the molecular level [62,63]. Since we
demonstrate that mammalian Cdc45 and PCNA can be recruited
to chromatin several hours prior to G1-S (at least in MK cells), it
appears that the recruitment per se of Cdc45 and PCNA in somatic
mammalian cells does not itself constitute a G1-S trigger. This
suggests that further phosphorylation events, perhaps similar to
those identified in yeast, but independent of phosphorylation that
is required for Cdc45 and PCNA chromatin loading, are likely
required to initiate S-phase in mammalian cells.
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